Isaac Yaw Attah

Isaac Yaw Attah

Auto-generated profile, based on publicly available information

Isaac Yaw Attah

School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Cape Coast (UCC), Cape Coast, Ghana, ucc.edu.gh

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Heliyon
Verified
Journal Article
Open access
EAEmmanuel A. Adakudugu
Emmanuel A. Adakudugu
EAElvis O. Ameyaw
Elvis O. Ameyaw
EOErnest Obese
Ernest Obese
RBRobert P. Biney
Robert P. Biney
IHIsaac T. Henneh
Isaac T. Henneh
DODavid D. Obiri
David D. Obiri
Bergapten (5-methoxysporalen) is a furanocoumarin extracted from several species of citrus and bergamot oil. Bergamot essential oil is used traditionally in the management of inflammatory conditions. Previous studies on bergapten have explored mainly its in vitro anti-inflammatory activities which include suppression of the expression and release of pro-inflammatory cytokines such as TNF-α and interleukins as well as prostaglandins. Bergapten enhances the clearance of neutrophils and macrophages from the site of inflammation and reduces oxidative stress by inhibition of reactive oxygen species (ROS). Bergapten was assessed for its anti-inflammatory properties in acetic acid-induced colitis. Animals were obtained and randomly placed in six (6) groups (n = 5) after acclimatization. Colitis was induced by rectal administration using 4% v/v acetic acid in Sprague Dawley rats after pre-treatment for 5 days. Bergapten was administered at doses of 3, 10, and 30 mg kg−1p.o. while the control group received saline 5 mL kg−1p.o. and the standard drug employed was sulphasalazine at a dose of 500 mg kg−1. Assessments made for colon-weight-to-length ratio, colonic injury, and mucosal mast cell degranulation. There were reduced colon-weight-to-length ratios in animals treated with bergapten which was significant (p < 0.5) for doses 10 and 30 mg kg−1 compared to the disease control group Both macroscopic and microscopic damage were reduced as well, with a lesser percentage of degranulated mast cells. Macroscopic damage was reduced for bergapten at doses 10 and 30 mg kg−1 significantly at p < 0.5 and p < 0.001, respectively. Similarly, microscopic damage was reduced at p < 0.01 and p < 0.001 respectively for bergapten 10 and 30 mg kg−1. The reduction of degranulation by bergapten was significant at p < 0.001. There was generally reduced damage at inflammatory sites as well as decreased infiltration of inflammatory cells. Overall, bergapten reduces inflammation in acetic acid-induced colitis.

5 December 2023 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
OAOfosua Adi-Dako
Ofosua Adi-Dako
FOFrederick William Akuffo Owusu
Frederick William Akuffo Owusu
IAIsaac Yaw Attah
Isaac Yaw Attah
DKDoris Kumadoh
Doris Kumadoh
PJPrince George Acquah Jnr
Prince George Acquah Jnr
MAMary-Ann Archer
Mary-Ann Archer
A combination of inorganic and organic hybrid systems is of high research interest as they provide novel hybrid systems for the improvement of existing properties, overcoming limitations of the parent materials, and for the optimization of their controlled release potential. This study sorted to develop and pharmaceutically assess the release profile of diclofenac sodium using cocoa pod husk (CPH) blended with different proportions of either talc or bentonite as multiparticulate composite release modifiers. Preformulation investigations of the multiparticulate hybrid systems included pH, swelling index, moisture content, elemental contents, and flow properties. The FTIR was also used to investigate the compatibilities between pectin and bentonite (PB), pectin and talc (PT), and diclofenac and pectin-talc (DPT), as well as diclofenac and pectin-bentonite (DPB). The diclofenac content, uniformity of the weight of capsules, in vitro drug release, and the kinetics and mechanism of release of diclofenac from the hybrid systems were also investigated using mathematical models. The pectin yield was 23.3, with the water-holding capacities of pectin-talc (PT) and pectin-bentonite (PB) hybrid systems being 6.4 and 5.0, respectively. The swelling indices of PT and PB were 110.0 and 130.0 in 0.1M HCL at pH 1.2 and 130.0 and 149.0 in phosphate buffer at pH 6.8, respectively. This system was also found to exhibit excellent flow properties, and there were no diclofenac-excipient interactions. All formulated batches passed the pharmacopoeial and nonpharmacopoeial tests. They also demonstrated controlled release properties via different release kinetics and mechanisms. This study shows that the pectin-talc and pectin-bentonite multiparticulate composites could be used as release modifiers in pharmaceutical preparations.

1 January 2026 in International Journal of Analytical Chemistry
Verified
Journal Article
Open access
BABarbara Adu-Brimpong
Barbara Adu-Brimpong
ABAbena Amponsaa Brobbey
Abena Amponsaa Brobbey
JAJoseph Kwasi Adu
Joseph Kwasi Adu
JAJohn Nii Adotey Addotey
John Nii Adotey Addotey
MAMustapha Kobina Abeka
Mustapha Kobina Abeka
IAIsaac Yaw Attah
Isaac Yaw Attah
Honey is a nutritive sugar alternative, well‐accepted over decades due to its natural source, and a global populace drive toward natural and healthier lifestyle options. Its quality assessment includes 5‐hydroxymethylfurfural (5‐HMF) content, which measures freshness, but has been linked to cancer. The ability to test for this neo‐formed contaminant, 5‐HMF, should therefore not be compromised, even in a resource‐constrained setting. In this study, a modified reversed‐phase HPLC method for the assay of 5‐HMF levels in honey has been developed. A nonpolar C‐18 column of dimension 3.0 × 150 mm; 2.7 μm was the stationary phase of choice, while a combination of 10:90% v/v of methanol and distilled water, with 1% formic acid, was employed as the mobile phase. Detection was by diode array at a wavelength of 295 nm, using an injection volume of 1 μL. At a flow rate of 0.5 mL/min, the total runtime of the method was 8 min, with the average retention time for 5‐HMF recorded at 3.87 ± 0.05 min. Validation of the method was conducted using International Council for Harmonisation guidelines, over the range of 1.25–30.0 μg/mL. It was further employed to quantify 5‐HMF in 20 honey samples on the Ghanaian market with varying origin, extraction source and production state, using methanol as the dissolution solvent to ensure stability of the target compound throughout the analysis. 5‐HMF levels assayed in the honey samples ranged from 0.8176 ± 0.182 to 81.1619 ± 2.1169 mg/kg of honey. At the time of analysis, 5‐HMF contents of all samples except one were within the acceptable limit of ≤ 80 mg/kg of honey, set by the International Honey Commission. The 5‐HMF levels quantified in market samples approved by Ghana’s Food and Drugs Authority were within the acceptable limit. The developed method is comparatively cheaper and can be successfully used to analyse 5‐HMF in honey samples.